MENU
NCEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NewcelX (NCEL) Ownership - Who owns NewcelX?

NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.81M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.68
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

NCEL
Capitalization
11.8M
P/E Ratio
N/A
Risk (Beta)
0.68
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
N/A
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-20.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
0.02
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-27.33M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-1798.47
Shares Held By Institutions
42.6K
Shares Outstanding - Current
4.56M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
-1
Gain YTD
36.842
View a ticker or compare two or three
NCEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details